Sep 16, 2026 07:42AM
Aug 6, 2026 05:55PM
Jul 29, 2026 12:26PM
Jun 9, 2026 07:30AM
May 15, 2026 07:33AM
May 7, 2026 04:24PM
Apr 20, 2026 07:30AM Goldman Sachs sees nearly 140% upside in this biopharma stock
Apr 17, 2026 04:34AM
Apr 13, 2026 05:52AM
Mar 13, 2026 08:51AM
Mar 13, 2026 07:23AM
Mar 13, 2026 06:26AM
Mar 12, 2026 04:02PM
Jan 23, 2026 07:23AM Corvus Pharmaceuticals (CRVS) Reiterated at Overweight by Cantor Fitzgerald
Jan 22, 2026 12:22PM
Jan 21, 2026 07:07AM
Jan 20, 2026 06:09PM
Jan 20, 2026 04:26PM
Jan 20, 2026 12:30PM
Dec 11, 2025 06:52AM
Nov 4, 2025 04:17PM Corvus Pharmaceuticals, Inc. (CRVS) Tops Q3 EPS by 1c
Oct 13, 2025 05:30AM
Aug 7, 2025 04:13PM
Jun 25, 2025 08:02AM
Jun 25, 2025 06:36AM
Jun 12, 2025 07:23AM
Jun 4, 2025 07:01AM
May 20, 2025 05:33AM Corvus Pharmaceuticals (CRVS) PT Lowered to $11 at Mizuho
May 12, 2025 05:59AM
May 8, 2025 04:14PM
May 8, 2025 04:03PM
Apr 9, 2025 04:02PM
Mar 26, 2025 06:49AM
Mar 25, 2025 04:01PM
Mar 20, 2025 08:03AM Corvus Pharma (CRVS) Announces Presentation of Additional Data from the Phase 1/1b Clinical Trial of Soquelitinib for Patients with T Cell Lymphoma
Mar 12, 2025 08:01AM
Jan 13, 2025 07:30AM
Dec 23, 2024 05:34AM
Dec 19, 2024 06:38AM
Dec 18, 2024 08:08AM
Dec 18, 2024 07:33AM
Dec 18, 2024 07:30AM Corvus Pharma (CRVS) Announces Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib
Dec 17, 2024 04:49PM
Dec 17, 2024 04:01PM
Dec 4, 2024 04:06PM
Nov 14, 2024 10:01AM
Nov 13, 2024 01:24PM
Nov 12, 2024 04:03PM
Oct 22, 2024 06:05AM Mizuho Upgrades Corvus Pharmaceuticals (CRVS) to Outperform
Sep 16, 2024 06:48AM

466,034 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All